KKR & Co to acquire Bushu Pharmaceuticals from BPEA EQT.

KKR & Co, a global investment firm, agreed to acquire Bushu Pharmaceuticals, a provider of contract manufacturing services, from BPEA EQT, a Asian private equity firm. Financial terms were not disclosed. “We are proud to invest in the growth and success of Bushu Pharma, a premier manufacturer for pharmaceutical businesses. We see significant demand for strategic and reliable solutions to address a range of challenges facing the global healthcare industry. By leveraging KKR’s deep experience in healthcare, tech, and supply chain solutions, we aim to help Bushu Pharma to further scale its best-in-class business and to drive growth and technical innovation that will ultimately benefit patients in Japan and around the world," Hiro Hirano, KKR Co-Head of Private Equity for Asia Pacific and CEO of Japan.